OA09191A - Use of certain gamma interferons for the preparation of pharmaceutical compositions intended for the treatment of ovarian cancer by the intraperitoneal route. - Google Patents

Use of certain gamma interferons for the preparation of pharmaceutical compositions intended for the treatment of ovarian cancer by the intraperitoneal route.

Info

Publication number
OA09191A
OA09191A OA59732A OA59732A OA09191A OA 09191 A OA09191 A OA 09191A OA 59732 A OA59732 A OA 59732A OA 59732 A OA59732 A OA 59732A OA 09191 A OA09191 A OA 09191A
Authority
OA
OAPI
Prior art keywords
ovarian cancer
treatment
preparation
pharmaceutical compositions
compositions intended
Prior art date
Application number
OA59732A
Other languages
French (fr)
Inventor
Brandely Maud
Lando Danielle
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA09191(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of OA09191A publication Critical patent/OA09191A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Use of a recombinant polypeptide having an activity of the human gamma-interferon type for preparing a pharmaceutical composition which can be administered intraperitoneally in perfusion and is intended for the effective treatment of ovarian cancer.
OA59732A 1989-02-02 1990-02-02 Use of certain gamma interferons for the preparation of pharmaceutical compositions intended for the treatment of ovarian cancer by the intraperitoneal route. OA09191A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8901346A FR2644067B1 (en) 1989-02-02 1989-02-02 USE OF CERTAIN GAMMA INTERFERONS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OVARY CANCER BY THE INTRAPERITONEAL ROUTE

Publications (1)

Publication Number Publication Date
OA09191A true OA09191A (en) 1992-06-30

Family

ID=9378406

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59732A OA09191A (en) 1989-02-02 1990-02-02 Use of certain gamma interferons for the preparation of pharmaceutical compositions intended for the treatment of ovarian cancer by the intraperitoneal route.

Country Status (12)

Country Link
EP (1) EP0381584B1 (en)
JP (1) JPH0772137B2 (en)
KR (1) KR100203316B1 (en)
AT (1) ATE99954T1 (en)
AU (1) AU632528B2 (en)
CA (1) CA2009106A1 (en)
DE (1) DE69005837T2 (en)
DK (1) DK0381584T3 (en)
FR (1) FR2644067B1 (en)
HU (1) HU204711B (en)
OA (1) OA09191A (en)
ZA (1) ZA90671B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
WO1987005518A1 (en) * 1986-03-17 1987-09-24 Schering Corporation Treatment of cancers with gamma interferon

Also Published As

Publication number Publication date
HU900202D0 (en) 1990-03-28
JPH02235818A (en) 1990-09-18
EP0381584B1 (en) 1994-01-12
CA2009106A1 (en) 1990-08-02
DE69005837D1 (en) 1994-02-24
AU4895390A (en) 1990-08-09
JPH0772137B2 (en) 1995-08-02
KR900012628A (en) 1990-09-01
EP0381584A3 (en) 1991-11-06
ATE99954T1 (en) 1994-01-15
ZA90671B (en) 1991-04-24
AU632528B2 (en) 1993-01-07
HU204711B (en) 1992-02-28
EP0381584A2 (en) 1990-08-08
HUT54302A (en) 1991-02-28
FR2644067B1 (en) 1993-02-05
DE69005837T2 (en) 1994-05-11
FR2644067A1 (en) 1990-09-14
KR100203316B1 (en) 1999-06-15
DK0381584T3 (en) 1994-02-14

Similar Documents

Publication Publication Date Title
IT1179635B (en) COMPOSITION AND PREPARATION FOR THE ADMINISTRATION OF MEDICATIONS BY SKIN
FR2576791B1 (en) PHARMACEUTICAL COMPOSITION BASED ON HUMAN ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA OF MALIGNANT TUMORS
DE69534676D1 (en) Oral administration of chemically modified proteins
OA09317A (en) "Use of a polypeptide having the activity of human interleukin 2 for the preparation of pharmaceutical compositions for the treatment of leukemias".
ATE67783T1 (en) HOMOGENEOUS RECOMBINANT IMMUNE INTERFERON FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2587216B1 (en) PHARMACEUTICAL COMPOSITION BASED ON HUMAN ERYTHROPOIETIN FOR NASAL ADMINISTRATION FOR THE TREATMENT OF ANEMIA
DE68909267T2 (en) Drug for the treatment of fibrotic disorder and antifibrotic compound.
FR2660863B1 (en) USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PRIMITIVE CANCERS OF THE POWDER.
DE69001686T2 (en) TREATING LEUCOCYTIC DISORDERS WITH GM-CSF.
OA09191A (en) Use of certain gamma interferons for the preparation of pharmaceutical compositions intended for the treatment of ovarian cancer by the intraperitoneal route.
ATE428438T1 (en) MEDICAL COMPOSITION CONTAINING TCF-II
DE3788899T2 (en) Intralesional treatment of basal cell carcinoma using recombinant human alpha interferons.
DE3869789D1 (en) TREATMENT OF SOME LEUKAEMIA WITH A COMPOSITION OF INTERFERON-GAMMA AND INTERFERON-ALPHA.
BE904586A (en) UROGASTRONE.
OA09469A (en) Use of a polypeptide having the activity of gamma interferon for the preparation of pharmaceutical compositions intended for the treatment of primary cancers of the pleura.
FR2601950B1 (en) N, N-DIMETHYL-N'-BENZOYL-N '((2,3-DIHYDRO) BENZOFURAN-2-YL-METHYL) 1,3-PROPANEDIAMINE, PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
OA09530A (en) Use of a polypeptide having the activity of human interleukin 2 for the preparation of pharmaceutical compositions intended for the treatment of pneumothoraxes
FR2568124B1 (en) MEDICINE FOR TREATING HYPOTROPHIC CONDITIONS BY ADMINISTRATION OF ARGININE ASPARTATE
FR2598616B1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATION PHENOMENA IN MAMMALS
FR2602680B1 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION
IT1246050B (en) USE OF HEPTASTIGMIN IN CEREBRAL STROKE THERAPY.
IT8847847A0 (en) DEVICE FOR THE DELIVERY OF COMPOUND AND BALSAMIC THERAPEUTIC OXYGEN